Clinical Trial Update: Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial completion update for two digital therapeutics targeting experiential negative symptoms in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Digital Therapeutic 1
• Digital Therapeutic 2

Snippet

Sponsor: Click Therapeutics, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED